Coventry mum's relief over 'brutally unfair' drug access
A Coventry mother is "massively relieved" after being told her daughter will now have access to a life-enhancing drug indefinitely. Phoebe's six-year-old daughter Flory lives with CLN2 Batten disease, a rare and untreatable genetic disorder affecting about 40 children in the UK. After months of uncertainty, health bosses this week revealed those already taking or soon to start treatment could continue to have it beyond the end of May.But Phoebe believes it is also "brutally unfair" not all young people affected will benefit, and has vowed to keep fighting so everyone can access the drug.
CLN2 Batten disease causes a rapid decline in a child's ability to walk, talk and see, with an average life expectancy of about 10 years. Drug Brineura is the only approved treatment that slows the condition's progress, but NHS access was due to end in May. The National Institute for Health and Care Excellence (NICE) revealed on Thursday NHS England (NHSE) had come to a new agreement with its maker, BioMarin, regarding existing patients.But it costs about £500,000 per child per year, and is not being recommended for future patients "due to its high price and the limited evidence of long-term effectiveness".
After she had receiving confirmation Flory's fortnightly treatment would continue, Phoebe said: "Families will see our children living longer with a better quality of life, while being completely hopeless."
She said getting the drug on the NHS had been "absolutely monumental" for Flory, and she believed her daughter was still walking, climbing and eating thanks to it. "To know that she's going to have access to this indefinitely... is everything," she said. "This treatment completely changes the trajectory of her life. Before, her entire life was uncertain." But while it is a massive relief for her family, she is determined to keep advocating for others. Phoebe urged decision makers to do the right thing, adding they were "halfway there". "Every child should be able to access this treatment," she said. "It is is life-changing. To offer it some and not others seems brutally unfair."
NICE said it would keep working with NHSE and BioMarin towards a long-term deal for all patients after a managed access agreement ended in December. "We know this is not entirely the news people in the Batten Disease community were hoping for," said NICE director of medicines evaluation Helen Knight."However, this is not the end of the story. We will continue to work with all parties towards a solution."The Batten Disease Family Association said it was pleased with the agreement, but would continue to push for Brineura to be accessible for all children.
Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and Instagram.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
42 minutes ago
- The Independent
The NHS will receive £6bn in funding. Here's how it will be used
Rachel Reeves has pledged a £6bn investment to accelerate NHS tests and treatments, following substantial budget increases. The funding aims to provide new scanners, ambulances, and urgent treatment centres, delivering up to four million more tests and procedures in five years. This investment supports the government's goal of reducing NHS waiting lists in England, with Labour aiming for 92 per cent of routine operations to be carried out within 18 weeks. Health Secretary Wes Streeting said the investment will generate millions more diagnostic tests, scans, and procedures, building on 3.6 million extra elective care appointments already delivered. Health leaders are sceptical, with Matthew Taylor of the NHS Confederation warning that the £29bn increase may not cover rising costs and guarantee waiting time targets, while Sarah Woolnough of the King's Fund questions how all NHS needs can be met with this settlement alone.
BBC News
an hour ago
- BBC News
Jersey minister responds to PFAS report recommendations
Jersey's environment minister said he had taken "quick action to respond to recommendations" from an independent report into ground water supplies contaminated by potential harmful chemicals, called polyfluoroalkyl substances (PFAS).The report by Arcadis consulting published in May found a bigger area of ground water in Jersey was affected by PFAS than previously Steve Luce wrote in a government response to the report that he "fully accepted the majority of the report's recommendations".The minister will hold a public meeting next week to discuss his response to the report. One of the actions he has taken is establishing a "hydrogeological PFAS steering group, bringing together officers from Government of Jersey, Ports of Jersey and Jersey Water".Luce said: "The group will play a central role in ensuring that remediation efforts are proportionate, technically feasible and focused on reducing environmental and public health risks."The minister added further testing of water, soil and outfalls is underway to address gaps in knowledge, and additional monitoring will take place this summer to track the movement of PFAS from and around the airport site. 'Advice provided' In its response to the Arcadis consulting report, the government outlined how they had identified 16 properties "in the plume area".It said: "All residential addresses and business addresses within this area, which have a borehole registered for drinking or which are not connected to the mains water supply have been contacted by officers."Testing of impacted borehole water is being arranged as necessary, and advice on the use of water on an individual basis is being provided."Jersey Water and Ports of Jersey also contributed to the government response to the of Jersey CEO, Matt Thomas sent the BBC a statement which said: "We are now playing an active role in the steering group established by government to develop a remediation strategy, which will determine which actions to take based on the recommendations of the report."As this strategy is developed, we will be guided by a sense of duty to the environment and the health of affected islanders." Jersey Water said its policy was that affected water sources like the Port Marquet stream and St Ouen's boreholes would only be used once the contamination had been resolved. It added: "If the island faces a serious drought, these supplies may be needed but would only be used in conjunction with desalination plant to provide a dilution effect, ensuring that Jersey water continues to supply safe drink water."Luce said he wanted to "reassure Islanders" there was "no immediate risk to public health."He said: "Our public water supply continues to meet EU and UK standards for PFAS levels, and Jersey Water has already taken steps to avoid drawing from impacted sources."Properties previously affected by borehole contamination have been offered connections to the main supply to prevent further exposure."
BBC News
an hour ago
- BBC News
Birmingham trading standards find laughing gas sales despite ban
Shops are finding new ways to store and sell laughing gas canisters to "minors and anyone else who wants to buy them", a trading standards officer has oxide was categorised as a Class C drug in late 2023, making it a crime to possess or sell it for recreational Mohammed Tariq, a trading standards officer in Birmingham, said some deals had just "gone underground" in the city rather than BBC accompanied Mr Tariq on a raid on a shop in Birmingham, where he found a dozen laughing gas canisters. "As you can see, today it wasn't in the shop, the associated material was in the shop but the actual canisters were in the side alleyway," he said."From intelligence, nitrous is still being supplied - we are not seizing as many, but I just think they've gone underground."It is estimated that about 290 nitrous oxide canisters have been seized from shops in the city since last September, according to Birmingham City Council's trading standards department. Before the ban came into force in November 2023, laughing gas was one of the most commonly used recreational drugs by 16 to 24-year-olds and its use had soared during the are drawn to laughing gas because it is "fashionable" but it is "more harmful than cannabis", said a 25-year-old man from Birmingham who was a former user of the man, who did not want to be named, told the BBC he used the drug over a period of weeks but stopped after seeing the impacts on his health."It makes you feel like a zombie," he said. Nitrous oxide can make people feel relaxed and light-headed when inhaled, but it can also cause headaches, fainting, and make some users anxious. Heavy use can lead to a vitamin B12 deficiency that can damage nerves in the spinal gas remains legal in some settings – it is commonly used as a painkiller in medicine and dentistry, and it is also used to make whipped former user said shops would regularly sell laughing gas canisters to him and people he knew because "they are our friends".He added: "We would buy it from the shops, they don't say anything because they know us."In the year ending in March 2024, 0.9% of people aged 16-59 used nitrous oxide, down from 1.3% the previous year, according to the latest data from the Office for National was a rate of 3.3% amongst those aged 16 to 24, which showed no statistically significant change versus the previous year, although levels were lower compared to a decade earlier. Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.
